相关实验视频

Updated: May 23, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

只有双作用的PROTAC

Ranit Dutta^1,2, Anirudh Devarajan^1,2, Amelia Talluri¹

¹Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.

Journal of the American Chemical Society

|March 10, 2025

概括

这项研究介绍了一种新的药物技术 - - 单双作用PROTACs (DAO-PROTACs). 这些PROTAC需要低氧和cathepsin- L来激活,从而减少副作用并提高安全性.

科学领域:

药物发现和开发
分子生物学
生物化学

背景情况:

针对蛋白质分解的仿真体 (PROTACs) 是一种强效的伪催化剂.
在目标上,在场外的PROTAC可以导致不良后果.
有针对性的蛋白质降解提供了一个有前途的治疗策略.

研究的目的:

开发一个可通用的AND逻辑门的PROTAC系统,用于向蛋白质降解.
设计由双重疾病相关的内源刺激激活的PROTAC分子.
为了减轻与基于PROTAC的治疗相关的细胞毒性.

主要方法:

单双作用的PROTAC (DAO-PROTAC) 分子的设计和合成
开发一种需要低氧和甲素-L的双刺激激活机制.
与自由PROTAC和单刺激PROTAC相比,DAO- PROTAC活性和细胞毒性的评估

主要成果:

DAO- PROTACs处于休眠状态,直到被低氧和甲素- L的同时存在激活.
DAO- PROTACs的激活导致所需蛋白质 (POI) 的降解.
与传统的PROTAC相比,DAO- PROTAC的细胞毒性显著降低.

结论:

DAO-PROTAC代表了一种用于精确蛋白质降解的新AND逻辑门式方法.
双刺激激活提高了基于PROTAC的治疗方法的安全性.
这项技术有可能为更安全,更有效的向蛋白质降解疗法提供帮助.

更多相关视频

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

A Protocol for Real-time 3D Single Particle Tracking

A Protocol for Real-time 3D Single Particle Tracking

Published on: January 3, 2018

相关概念视频

Receptor Tyrosine Kinases

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...